Phase 2 study to investigate the efficacy and safety of ZK-epothilone (ZK-Epo; ZK 219477) [sagopilone] in patients with metastatic breast cancer
Phase of Trial: Phase II
Latest Information Update: 12 Dec 2015
At a glance
- Drugs Sagopilone (Primary)
- Indications Advanced breast cancer
- Focus Therapeutic Use
- Sponsors Bayer; Berlex Inc
- 12 Feb 2009 Status changed from recruiting to completed, as reported by ClinicalTrials.gov.
- 12 May 2006 New trial record.